Page last updated: 2024-10-30

lansoprazole and Behcet Syndrome

lansoprazole has been researched along with Behcet Syndrome in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.

Research Excerpts

ExcerptRelevanceReference
"Lansoprazole (30 mg) was given as a probe drug to evaluate CYP2C19 activity in 59 patients with BD and 27 healthy control volunteers."1.46Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behçet's Disease. ( Akdogan, A; Babaoglu, MO; Bertilsson, L; Bozkurt, A; Cevik, L; Goktas, MT; Kalkisim, S; Karaca, RO; Kilic, L; Yasar, U, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goktas, MT1
Karaca, RO1
Kalkisim, S1
Cevik, L1
Kilic, L1
Akdogan, A1
Babaoglu, MO1
Bozkurt, A1
Bertilsson, L1
Yasar, U1
Kobayashi, S1
Kawabe, N1
Miyata, F1
Ito, H1
Kazumiya, H1
Murase, K1
Kurokawa, S1
Fujishima, K1

Other Studies

2 other studies available for lansoprazole and Behcet Syndrome

ArticleYear
Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behçet's Disease.
    Basic & clinical pharmacology & toxicology, 2017, Volume: 121, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents; Behcet Syndrome; Biotransformatio

2017
[A case of Behcet's syndrome associated with esophageal ulcer].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, Dec-10, Volume: 87, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Inflammatory Agents; Anti-Ulcer Agents; Behcet

1998